Publications by authors named "Syeda Zain"

Objective: Angiogenesis plays an important role in various physiological and pathological conditions and is essential for tumor growth and metastasis. The aim of this study was to evaluate the effect of a combination of vandetanib and celecoxib on angiogenic tube formation and its effect on angiogenic genes (MMP-2 and MMP-9) using an model of human umbilical vein endothelial cells (HUVECs).

Methods: HUVECs were cultured and verified by flow cytometry.

View Article and Find Full Text PDF

Objective: To compare the efficacy and safety of topiramate with gabapentin in the prophylaxis of migraine patients.

Methods: A 12-week randomised open label control trial was conducted at the Department of Pharmacology and Therapeutics, Basic Medical Sciences Institute, Jinnah Postgraduate Medical Centre (JPMC), Karachi from January to March 2011 involving 80 outpatients who had a history of migraine. The sample was divided into two equal groups.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Syeda Zain"

  • - Syeda Zain's recent research centers on the pharmacological effects of drug combinations in medical conditions, notably focusing on angiogenesis and migraine prophylaxis.
  • - A 2023 study demonstrated the impact of combining vandetanib and celecoxib on angiogenic processes by assessing their effects on angiogenic tube formation and related gene expression in human umbilical vein endothelial cells (HUVECs).
  • - Another notable work from 2013 compared the efficacy and safety of topiramate against gabapentin in preventing migraines, involving a controlled trial with 80 participants, revealing insights into treatment options for migraine patients.